about
Trial Watch: Proteasomal inhibitors for anticancer therapyMetastatic melanoma - a review of current and future drugsSensitization of melanoma cells to alkylating agent-induced DNA damage and cell death via orchestrating oxidative stress and IKKβ inhibitionProton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells.Metastatic melanoma to the brain: surgery and radiation is still the standard of care.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Fotemustine for the treatment of melanoma.
@en
Fotemustine for the treatment of melanoma.
@nl
type
label
Fotemustine for the treatment of melanoma.
@en
Fotemustine for the treatment of melanoma.
@nl
prefLabel
Fotemustine for the treatment of melanoma.
@en
Fotemustine for the treatment of melanoma.
@nl
P2860
P1476
Fotemustine for the treatment of melanoma.
@en
P2093
Gaëlle Quéreux
P2860
P304
P356
10.1517/14656566.2011.633513
P407
P577
2011-11-14T00:00:00Z